Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stem cell-enriched autologous fat grafting for breast reconstruction
2014-000510-59Phase 3Completed
- Sponsor
- Rigshospitalet Department of Plastic Surgery, Breast Surgery & Burns
- Start
- Jun 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of autologous adipose-derived mesenchymal stromal cells in Hypomastia (2 arms), sponsored by Rigshospitalet Department of Plastic Surgery, Breast Surgery & Burns. Primary endpoint: Residual volume of fat transplants at 1 year. Started Jun 2014; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
Hypomastia
Beyond the preview
Go deeper on 2014-000510-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000510-59.